L3042

Levocabastine hydrochloride

≥99% (HPLC), solid

• Synonim(y): Levophta, Levostin, R50547, [3S-[1(cis),3α,4β]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
• Wzór empiryczny (zapis Hilla): C₂₆H₂₉N₂O₂F·HCl
• Numer CAS: 79547-78-7
• Masa cząsteczkowa: 456.98
• UNSPSC Code: 12352200
• PubChem Substance ID: 329817402
• MDL number: MFCD07787408
• Assay: ≥99% (HPLC)
• Form: solid

Właściwości

• assay: ≥99% (HPLC)
• form: solid
• color: white
• solubility: DMSO: soluble ~10 mg/mL
• originator: Johnson & Johnson
• SMILES string: Cl[H].C[C@@H]1CN(CC[C@]1(C(O)=O)c2ccccc2)[C@@H]3CC[C@@](CC3)(C#N)c4ccc(F)cc4
• InChI: 1S/C26H29FN2O2.ClH/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20;/h2-10,19,23H,11-17H2,1H3,(H,30,31);1H/t19-,23-,25-,26-;/m1./s1
• InChI key: OICFWWJHIMKBCD-VALQNVSPSA-N
• Gene Information: human ... HRH1(3269)

Opis

Biochem/physiol Actions

Non-peptide histamine H₁ receptor antagonist; neurotensin NTS₂ receptor ligand.

Features and Benefits

This compound is featured on the Neurotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS07
• signalword: Warning
• hcodes: H315,H319,H335
• pcodes: P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• target_organs: Respiratory system
• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 3
• ppe: dust mask type N95 (US), Eyeshields, Gloves